ASPHALION | Exhibiting excellence with sheer expertise

Asphalion has been featured as one of the 10 Best Healthcare Solution Companies in 2022.

Asphalion has been featured as one of the 10 Best Healthcare Solution Companies in 2022.
January 16, 2023

News are out! We are proud to announce that Asphalion has been featured as one of the 10 Best Healthcare Solution Companies in 2022 by Insights Care.

As highlighted in the publication, under the leadership of our Managing Director, Núria Romero, digital solutions for Regulatory Affairs have been a priority in Asphalion for nearly 15 years, offering support to companies by helping them choose the right solutions for their specific business and Regulatory needs and supporting them during the entire process.

Also, Núria talks about the key challenges in the Healthcare sector: successful development and commercialization of medicines and Medical Devices; implementation of new technologies and risk management.

Have a look at the complete interview to read more about the challenges and how Asphalion is turning them into opportunities:

10 BEST HEALTHCARE SOLUTION COMPANIES IN 2022

For further information or queries you can contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | WORLD DRUG SAFETY CONGRESS EUROPE 2024

The World Drug Safety Congress offers the perfect setting to address how to drive pharmacovigilance operations forward for industry professionals, international regulatory bodies and academic representatives.

NEWS | Important Update from the FDA!

This guidance recommends steps manufacturers and applicants of active pharmaceutical ingredients (APIs) and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in drug products. The guidance also describes conditions that may introduce nitrosamine impurities. The unexpected finding of nitrosamine impurities, which are probable or possible human carcinogens, in certain drug products has made clear the need for a risk assessment strategy for the potential presence of nitrosamines in any drug product.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting